Form 6-K INTERMAP TECHNOLOGIES For: Nov 03

Tue, 03 Nov 2026 08:09:00 -0500

si-local-file:///var/storage/secattach/20261103/27277748.html

Intermap adds Terry Ryan, ex-Constellis CEO, to its board

Tue, 03 Nov 2026 07:30:16 -0500

Intermap Technologies (TSX: IMP; OTCQB: ITMSF) announced the appointment of Terry Ryan to its board of directors, according to a company statement.

Ryan brings experience from senior roles at several defense technology companies, including Science Applications International Corp. (SAIC), ManTech, Mercury Systems and Tenax Aerospace. He most recently served as CEO of Constellis, where he led development of LEXSO, an AI decision-support platform that integrates multi-domain sensor data on geospatial layers. He continues in a role as Executive Vice Chairman at Constellis.

Ryan also previously served as a professional staff member on U.S. Senate and House Intelligence oversight committees, as Director of

Intermap Appoints Terry Ryan to Board of Directors

Tue, 03 Nov 2026 07:30:00 -0500

Decades of experience growing dual-use defense technology companies

Trusted senior intelligence leader, with a record of accomplishment across strategic, tactical and policy roles

Former CEO of Constellis and Tenax Aerospace, global leaders in applied geospatial technology

DENVER, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in geospatial intelligence powered by proprietary 3D data, rapid image processing software and AI-driven analytics, today announced the appointment of Mr. Terry Ryan to its Board of Directors.

Intermap Appoints Terry Ryan to Board of Directors

Tue, 03 Nov 2026 07:30:00 -0500

Decades of experience growing dual-use defense technology companies

Trusted senior intelligence leader, with a record of accomplishment across strategic, tactical and policy roles

Former CEO of Constellis and Tenax Aerospace, global leaders in applied geospatial technology

Form 6-K INTERMAP TECHNOLOGIES For: Oct 16

Fri, 16 Oct 2026 11:50:00 -0500

si-local-file:///var/storage/secattach/20261016/27197087.html

Form 6-K INTERMAP TECHNOLOGIES For: Oct 07

Thu, 08 Oct 2026 06:01:00 -0500

si-local-file:///var/storage/secattach/20261008/27162941.html

Intermap acquires PCI Geomatics for $7.7M, targets $12-15M revenue

Wed, 07 Oct 2026 17:30:15 -0500

Intermap Technologies (TSX: IMP; OTCQB: ITMSF) completed its acquisition of PCI Geomatics Group Inc., which operates as CATALYST, on October 7, 2026, using $7.7 million in cash to finalize the transaction.

The deal followed shareholder approval on September 25, 2026, and a final order from the Ontario Superior Court of Justice dated September 28, 2026. Intermap acquired all outstanding PCI shares it did not already own under the Canada Business Corporations Act.

According to the company, the acquisition is expected to double Intermap's recurring revenue. PCI brings more than 30,000 installed software licenses across over 150 countries, along with optical image processing

Intermap Completes Acquisition of PCI Geomatics

Wed, 07 Oct 2026 17:30:00 -0500

Accelerates Intermap’s technology roadmap into distributed edge processing and microservices, extending proven and secure AI/ML analytics across thousands of autonomous geospatial workflows

Doubles recurring revenue, opening new commercialization pathways for Intermap’s AI/ML-driven image processing and downstream products, including solution enhancements for 30,000+ existing licenses in the commercial space market

Speeds delivery of decision-ready intelligence throughout Intermap’s asset-light platform, integrating our AI/ML analytics, large-scale, real-time, multi-domain 3D data with value-added software and APIs spanning complete-spectrum remote sensing on Earth, in the air, under sea and in space

Introducing 2027 commercial revenue guidance of

Intermap Completes Acquisition of PCI Geomatics

Wed, 07 Oct 2026 17:30:00 -0500

Accelerates Intermap’s technology roadmap into distributed edge processing and microservices, extending proven and secure AI/ML analytics across thousands of autonomous geospatial workflows

Doubles recurring revenue, opening new commercialization pathways for Intermap’s AI/ML-driven image processing and downstream products, including solution enhancements for 30,000+ existing licenses in the commercial space market

Speeds delivery of decision-ready intelligence throughout Intermap’s asset-light platform, integrating our AI/ML analytics, large-scale, real-time, multi-domain 3D data with value-added software and APIs spanning complete-spectrum remote sensing on Earth, in the air, under sea and in space

Introducing 2027 commercial revenue guidance of

Form 6-K INTERMAP TECHNOLOGIES For: Sep 28

Mon, 28 Sep 2026 07:45:00 -0500
si-local-file:///var/storage/secattach/20260928/27110143.html

Form 6-K INTERMAP TECHNOLOGIES For: Sep 28

Mon, 28 Sep 2026 07:45:00 -0500
si-local-file:///var/storage/secattach/20260928/27110143.html

Form 6-K INTERMAP TECHNOLOGIES For: Sep 21

Mon, 21 Sep 2026 07:45:00 -0500
si-local-file:///var/storage/secattach/20260921/27083059.html

Form 6-K INTERMAP TECHNOLOGIES For: Sep 21

Mon, 21 Sep 2026 07:45:00 -0500
si-local-file:///var/storage/secattach/20260921/27083059.html

Intermap Expands Global Insurance Business with Three-Year Fairfax Financial Subscription

Mon, 21 Sep 2026 07:30:00 -0500

Integrated flood risk and property valuation solution advances recurring revenue strategy and supports expansion across markets
DENVER, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in geospatial intelligence powered by proprietary 3D data and AI-driven analytics, today announced a three-year subscription agreement with Colonnade Insurance S.A. (“Colonnade”) for an integrated flood risk and property valuation solution. Colonnade is a Luxembourg-based non-life insurance company owned by Fairfax Financial Holdings, a Canadian international financial services holding company listed on the Toronto Stock Exchange. Through its subsidiaries, Fairfax is engaged in

Intermap Expands Global Insurance Business with Three-Year Fairfax Financial Subscription

Mon, 21 Sep 2026 07:30:00 -0500

Integrated flood risk and property valuation solution advances recurring revenue strategy and supports expansion across markets
DENVER, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in geospatial intelligence powered by proprietary 3D data and AI-driven analytics, today announced a three-year subscription agreement with Colonnade Insurance S.A. (“Colonnade”) for an integrated flood risk and property valuation solution. Colonnade is a Luxembourg-based non-life insurance company owned by Fairfax Financial Holdings, a Canadian international financial services holding company listed on the Toronto Stock Exchange. Through its subsidiaries, Fairfax is engaged in

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

Implantica to host Capital Markets Day in Stockholm on September 9

Tue, 25 Aug 2026 02:25:00 -0500

VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux, a treatment field with 1 billion sufferers, today announced that it will host a Capital Markets Day on September 9, 14:00-16:30 CEST in Stockholm.

"With FDA approval now secured, we are moving full speed ahead on our U.S. launch. This is a defining moment for Implantica and a huge opportunity to bring

StreetInsider.com News Articles

Form 6-K INTERMAP TECHNOLOGIES For: Nov 03

Intermap adds Terry Ryan, ex-Constellis CEO, to its board

Intermap Appoints Terry Ryan to Board of Directors

Intermap Appoints Terry Ryan to Board of Directors

Form 6-K INTERMAP TECHNOLOGIES For: Oct 16

Form 6-K INTERMAP TECHNOLOGIES For: Oct 07

Intermap acquires PCI Geomatics for $7.7M, targets $12-15M revenue

Intermap Completes Acquisition of PCI Geomatics

Intermap Completes Acquisition of PCI Geomatics

Form 6-K INTERMAP TECHNOLOGIES For: Sep 28

Form 6-K INTERMAP TECHNOLOGIES For: Sep 28

Form 6-K INTERMAP TECHNOLOGIES For: Sep 21

Form 6-K INTERMAP TECHNOLOGIES For: Sep 21

Intermap Expands Global Insurance Business with Three-Year Fairfax Financial Subscription

Intermap Expands Global Insurance Business with Three-Year Fairfax Financial Subscription

Implantica to host Capital Markets Day in Stockholm on September 9

Implantica to host Capital Markets Day in Stockholm on September 9

Implantica to host Capital Markets Day in Stockholm on September 9

Implantica to host Capital Markets Day in Stockholm on September 9

Implantica to host Capital Markets Day in Stockholm on September 9

Implantica to host Capital Markets Day in Stockholm on September 9

Implantica to host Capital Markets Day in Stockholm on September 9

Implantica to host Capital Markets Day in Stockholm on September 9

Implantica to host Capital Markets Day in Stockholm on September 9

Implantica to host Capital Markets Day in Stockholm on September 9